ARS Pharmaceuticals Inc (NASDAQ: SPRY)’s stock price has decreased by -2.75 compared to its previous closing price of 13.82. However, the company has seen a
ARS Pharmaceuticals Inc (NASDAQ: SPRY)’s stock price has gone rise by 4.31 in comparison to its previous close of 14.85, however, the company has experienced
SPRY has 36-month beta value of 0.83. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,”
ARS Pharmaceuticals Inc (NASDAQ: SPRY) has a price-to-earnings ratio of 159.58x that is above its average ratio. Additionally, the 36-month beta value for SPRY is
© 2024, Powered by Smart TechOne